A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy

Peer Review reports

Original Submission
13 Aug 2002	Submitted	Original manuscript
6 Sep 2002	Reviewed	Reviewer Report - Steven Kroft
2 Oct 2002	Reviewed	Reviewer Report - Philippe Gaulard
17 Oct 2002	Author responded	Author comments - Dan Jones
Resubmission - Version 2
17 Oct 2002	Submitted	Manuscript version 2
18 Nov 2002	Reviewed	Reviewer Report - Philippe Gaulard
2 Dec 2002	Author responded	Author comments - Dan Jones
Resubmission - Version 3
2 Dec 2002	Submitted	Manuscript version 3
Publishing
10 Dec 2002	Editorially accepted
10 Dec 2002	Article published	10.1186/1472-6890-2-5

Back to article page